Listeria monocytogenes genes supporting growth under standard laboratory cultivation conditions and during macrophage

Martin A Fischer1, Tim Engelgeh1, Patricia Rothe1

  • 1FG11 Division of Enteropathogenic Bacteria and Legionella, Robert Koch Institute, 38855 Wernigerode, Germany.

Genome Research
|September 16, 2022
PubMed

Insights

Transposon insertion sequencing identified essential genes for Listeria monocytogenes growth. This reveals new targets for developing drugs against this dangerous foodborne pathogen.

Area of Science:

  • Microbiology
  • Genomics
  • Pathogen Biology

Background:

  • Listeria monocytogenes is a Gram-positive bacterium prevalent in the environment.
  • Foodborne infections pose severe risks, especially to vulnerable populations.
  • Understanding pathogen cellular processes is crucial for developing control strategies.

Purpose of the Study:

  • To identify essential cellular processes for L. monocytogenes growth both in vitro and in vivo.
  • To discover novel targets for antilisterial drug development.

Main Methods:

  • Genome-wide transposon insertion sequencing (Tn-Seq) was applied to L. monocytogenes.
  • Analysis of gene requirements under standard laboratory conditions and during intracellular growth in macrophages.

Main Results:

  • 394 open reading frames essential for standard growth were identified.
  • 42 additional genes were essential for intracellular growth in macrophages.
  • Key processes identified include translation, cell division, envelope biosynthesis, cofactor biosynthesis, and unknown function genes.
  • Specific genes for intracellular growth include virulence factors, auxotrophy compensation, and cell division genes.
  • PASTA kinase signaling, glycine metabolism, and chromosome segregation were highlighted for viability and intracellular growth.

Conclusions:

  • Tn-Seq is effective for identifying essential genes in L. monocytogenes.
  • The study identified numerous genes critical for pathogen survival and virulence.
  • Findings suggest novel avenues for antilisterial drug discovery, targeting identified pathways and unknown genes.